ALNY vs GATX · P/E 76, rev $1.29B vs P/E 19, rev $1.16B
Alnylam Pharmaceuticals Inc (ALNY) versus GATX Corporation (GATX) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
GATX Corporation (GATX) is a rental & leasing services company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported GATX revenue for 2026-06-30 was $1.16B. Net income was $188.9M. Revenue was up 99.4% from 2026-03-31 to 2026-06-30. GATX currently screens at market cap $6.23B and trailing P/E 18.8.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. GATX currently screens at market cap $6.23B and trailing P/E 18.8.
Not investment advice. Open the ALNY and GATX stock pages for the full models.
Not investment advice.